middle.news
How Is dorsaVi Revolutionising Wearables with Neuromorphic AI and US Market Gains?
9:04am on Thursday 29th of January, 2026 AEDT
•
Technology
Read Story
How Is dorsaVi Revolutionising Wearables with Neuromorphic AI and US Market Gains?
9:04am on Thursday 29th of January, 2026 AEDT
Key Points
Over 100 new US physical therapy sites signed, driven by Select Medical partnership
Cash receipts from customers increased 50% to $280k in Q2 FY26
Mathew Regan appointed CEO to lead AI, RRAM, and robotics focus
Exclusive acquisition of neuromorphic Process-In-Memory IP from Technion
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
DORSAVI (ASX:DVL)
OPEN ARTICLE